Parental Efficacy and Control Questionnaire in Hematopoietic Stem Cell Transplant: Preliminary Validation
Menée aux Etats-Unis auprès de 185 parents d’enfants âgés de moins de 12 ans, atteints d’un cancer et ayant reçu une greffe de cellules souches hématopoïétiques, cette étude longitudinale analyse l’intérêt d’un outil permettant aux parents de mesurer leur sentiment d’auto-efficacité et de réduire la détresse psychologique de la famille
Objective : Develop and evaluate the preliminary validity of a self-report measure of parents’ treatment-related efficacy and control, Parental Efficacy and Control Questionnaire-Hematopoietic Stem Cell Transplant (PECQ-HCT), in a pediatric HCT sample. Methods : Participants included 185 parents of children (?12?years old) receiving HCT participating in a larger, longitudinal study. Parents completed the PECQ-HCT as well as measures of social problem-solving skills, collective family efficacy, family beliefs, and parental distress. Results : Exploratory factor analysis results indicated that a 37-item four-factor model was the best fitting and most theoretically sound, ?2(df = 1,596) = 14,089.95, p < .01, comparative fit index = 0.92, Tucker–Lewis Index = 0.90, and root mean square error of approximation = 0.07. Preliminary subscale scores demonstrated adequate internal consistency as well as good content and criterion-related validity. Conclusions : If replicated using a confirmatory factor analysis in a separate sample, these findings suggest that the four-factor PECQ-HCT measure may be useful for measuring HCT-related parental efficacy and perceived control.